Aft, Forsyth & Company, Inc. Pfizer Inc Transaction History

Aft, Forsyth & Company, Inc.

$192 Million
Q2 2024

A detailed history of Aft, Forsyth & Company, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Aft, Forsyth & Company, Inc. holds 8,545 shares of PFE stock, worth $224,220. This represents 0.12% of its overall portfolio holdings.

Number of Shares

8,545

Previous 7,575 12.81%

Holding current value

$224,220

Previous $210,000 13.81%

% of portfolio

0.12%

Previous 0.12%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$25.26 - $29.6 $24,502 - $28,712	970 Added 12.81%	8,545 $239,000
Q1 2024 Apr 30, 2024	SELL	$25.89 - $29.73 $105,449 - $121,090	-4,073 Reduced 34.97%	7,575 $210,000
Q4 2023 Feb 09, 2024	SELL	$26.13 - $33.94 $29,396 - $38,182	-1,125 Reduced 8.81%	11,648 $335,000
Q3 2023 Nov 07, 2023	SELL	$32.09 - $37.51 $23,265 - $27,194	-725 Reduced 5.37%	12,773 $423,000
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $37,926 - $43,879	-1,050 Reduced 7.22%	13,498 $495,000
Q2 2022 Jul 28, 2022	BUY	$46.53 - $55.17 $38,387 - $45,515	825 Added 6.01%	14,548 $763,000
Q1 2022 May 10, 2022	BUY	$45.75 - $56.69 $9,150 - $11,338	200 Added 1.48%	13,723 $710,000
Q4 2021 Feb 07, 2022	BUY	$41.32 - $61.25 $42,353 - $62,781	1,025 Added 8.2%	13,523 $799,000
Q2 2021 Jul 15, 2021	BUY	$35.91 - $40.68 $18,852 - $21,357	525 Added 4.38%	12,498 $489,000
Q4 2020 Feb 09, 2021	SELL	$33.47 - $42.56 $6,526 - $8,299	-195 Reduced 1.6%	11,973 $441,000
Q3 2020 Nov 05, 2020	SELL	$31.75 - $37.25 $4,762 - $5,587	-150 Reduced 1.22%	12,168 $447,000
Q1 2020 May 11, 2020	SELL	$27.03 - $38.62 $54,060 - $77,240	-2,000 Reduced 13.97%	12,318 $381,000
Q4 2019 Feb 10, 2020	SELL	$32.92 - $37.36 $7,407 - $8,406	-225 Reduced 1.55%	14,318 $561,000
Q3 2019 Nov 12, 2019	SELL	$32.49 - $42.13 $4,873 - $6,319	-150 Reduced 1.02%	14,543 $523,000
Q2 2019 Jul 29, 2019	BUY	$36.98 - $41.52 $22,187 - $24,912	600 Added 4.26%	14,693 $637,000
Q1 2019 May 08, 2019	BUY	$37.5 - $41.2 $4,687 - $5,150	125 Added 0.89%	14,093 $599,000
Q4 2018 Feb 05, 2019	SELL	$38.47 - $43.86 $3,577 - $4,078	-93 Reduced 0.66%	13,968 $610,000
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $3,067 - $3,269	93 Added 0.67%	14,061 $510,000
Q1 2018 May 14, 2018	SELL	$31.91 - $37.02 $17,805 - $20,657	-558 Reduced 3.84%	13,968 $496,000
Q4 2017 Feb 12, 2018	BUY	$33.26 - $35.29 $483,134 - $512,622	14,526	14,526 $526,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $147B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aft, Forsyth & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Aft, Forsyth & Company, Inc. with notifications on news.

Account

Aft, Forsyth & Company, Inc. Pfizer Inc Transaction History